Ingenuity pathway analysis demonstrated alterations in several pathways in BM ECs in response to anti-NRP1, including organismal survival, hematological system development and function, hematopoiesis, cardiovascular disease and hematologic disease pathways (Fig. 7a). Here, NRP1 is linked to cardiovascular disorder.